Gastric cancer location
Source: Clujul Medical. Jun, Vol.
Stomach (Gastric) Cancer - Stephanie’s Story
Author s : VintilĂ, Marius; Andercou, Aurel; Duse, Adrian Abstract: Gastric neoplasm is one of the most common digestive tract cancers, entailing a high mortality rate. The gold standard in the diagnosis of gastric neoplasm and gastric cancer location complications is upper GI endoscopy associated with biopsy and histological testing, both for the screening and the individual diagnosis.
Patients come to gastric cancer location doctor relatively late mainly due to non-specific and nonsystematic symptomatology ; in Romania gastric cancer location cases are diagnosed at stages III or IV.
The natural evolution of the disease varies according to the histological type, shape and location at the time of diagnosis, as well as the frequency, onset and especially severity of complications. The complications of gastric cancer are of paramount importance gastric cancer location the evolution, as they are often the direct cause of the patient's death.
The prognosis of the disease is closely correlated with the tumoral stage at the time of diagnosis, and surgical treatment still remains the only method to improve survival rate, especially in the early stages.
English Copyright of Clujul Medical is the property of Cluj Medical University and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged.
No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. Important Gastric cancer location Information: Remote access to EBSCO's databases is permitted to patrons of subscribing institutions accessing from remote locations for personal, non-commercial use.
However, remote access to EBSCO's databases from non-subscribing institutions is not allowed if the purpose of the use cervical cancer and lymph nodes for commercial gain through cost reduction or avoidance for a non-subscribing institution.